Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-03

Clinical Trial Update: Topical Betaxolol for the Prevention of Retinopathy of Prematurity [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating topical betaxolol for the prevention of retinopathy of prematurity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaxolol (Betaxolol)

Snippet

Sponsor: Smith-Kettlewell Eye Research Institute | Conditions: Development of Side Effects From Betaxolol | Phase 1 | Status: COMPLETED